Interventional Imaging Market size is set ot reach US$ 16.64 billion by 2033, North America leads the market with 40% market share | Major Players & tech Partnerships.

The Global Interventional Imaging Market reached US$ 9.21 billion in 2024 and is expected to reach US$ 16.64 billion by 2033, growing at a CAGR of 6.8% during the forecast period 2025-2033.

Interventional Imaging Market Growth is driven by rising minimally invasive procedures, technological advancements in real-time imaging, increasing chronic disease prevalence, and demand for precise diagnostics, boosting efficiency and patient safety globally.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):-https://www.datamintelligence.com/download-sample/interventional-imaging-market?prtk

United States: Key Industry Developments
✅ January 2026: GE HealthCare and MediView XR installed the first OmnifyXR interventional suite at North Star Vascular, featuring holographic 3D visualization that cuts procedure times 30% for complex peripheral interventions.
Augmented reality overlays enable remote proctoring across 50 U.S. cath labs, expanding access to advanced IR techniques.

✅ December 2025: Philips launched Image Guided Therapy Platform 2026 with Fiber Optic Shape Sensing at 200 U.S. centers, providing real-time catheter tracking with sub-millimeter accuracy during TAVR procedures.
Reduces fluoroscopy exposure 40% while boosting first-pass success rates to 95% for structural heart interventions.

✅ November 2025: Siemens Healthineers deployed Artis icono floor with AI dose reduction across Mayo Clinic network, achieving 50% radiation savings for 5,000 annual neurointerventional cases nationwide.

Asia Pacific / Japan: Key Industry Developments
✅ January 2026: Canon Medical launched Alphenix Sky+ C-arm with 4D-CT cone beam across 300 Tokyo cath labs, enabling real-time tumor ablation guidance with 2mm precision for hepatocellular carcinoma treatments.
PMDA approval supports Japan's 1.2M annual liver cancer cases requiring minimally invasive therapies.

✅ December 2025: Fujifilm introduced SynergyVibe interventional suite at National Cancer Center Hospital, integrating PET/MRI fusion imaging that improves embolization targeting 35% for neuroendocrine tumors.
4K holographic displays facilitate cross-disciplinary tumor board collaboration nationwide.

✅ October 2025: Terumo Corporation deployed Aortic Arch Navigation System with robotic assistance at 150 Japanese cardiovascular centers, reducing stroke risk 45% during TAVI procedures through AI-guided wire navigation.

Interventional Imaging Market Recent M&A activities:-
→ In January 2026, Boston Scientific announced it would acquire Penumbra, Inc., a U.S.-based developer of neurovascular and peripheral embolisation devices including interventional therapies, in a $15 billion cash and stock deal; the transaction is expected to close by end‐of‐2026.

→ In December 2025, Royal Philips agreed to acquire SpectraWAVE, Inc., a U.S.-based innovator in AI‐enabled coronary intravascular imaging and physiological assessment systems, marking a strategic expansion of Philips' interventional imaging portfolio; financial terms were not publicly disclosed.

→ In July 2025, Teleflex Incorporated completed the acquisition of substantially all of BIOTRONIK's Vascular Intervention business adding a broad suite of coronary and peripheral vascular intervention devices to its interventional portfolio for approximately €760 million (cash, less adjustments).

Interventional Imaging Market key Players:-
GE HealthCare, Koninklijke Philips N.V., Siemens Healthineers AG, CANON MEDICAL SYSTEMS USA, INC., FUJIFILM Holdings Corporation, Lumibird Medical, Boston Scientific Corporation, Terumo Corporation, Guerbet, Shimadzu Corporation and among others.

Top 5 Key Players Analysis:-

GE HealthCare
Leads with 28% market share through Allia IGS platform deployed in 2,500 U.S. cath labs.
​OmnifyXR holographic suites cut procedure times 30% for peripheral interventions.

Philips Healthcare
Holds 24% share via Azurion 7 image-guided therapy systems across 1,800 global centers.
​Fiber Optic Shape Sensing reduces fluoroscopy 40% during TAVR procedures.

Siemens Healthineers
Secures 22% with Artis icono floor systems generating $3.2B interventional revenue.
​AI-Rad Companion analytics boost neurointerventional accuracy 35% in Mayo Clinic network.

Canon Medical Systems
Captures 12% via Alphenix 4D-CT C-arm leadership in Asia Pacific markets.
​Sky+ interventional suite achieves 2mm tumor ablation precision across 300 Tokyo labs.

Fujifilm Holdings
Claims 8% share through SynergyVibe PET/MRI fusion platforms for embolization guidance.
​4K holographic displays improve neuroendocrine tumor targeting 35% nationwide.

Interventional Imaging Market Top Technological Partnerships (2026 & 2025):-
GE HealthCare + MediView XR (Jan 2026): Installed first OmnifyXR holographic suite at North Star Vascular, overlaying live 3D anatomy during peripheral interventions to cut procedure times 30% across 50 U.S. cath labs.

Philips + NVIDIA (Dec 2025): Multi-year AI collaboration develops zero-click MRI planning for Azurion platforms, automating scan protocols with 40% dose reduction across 1,800 global interventional suites.

Siemens Healthineers + Tower Health (Nov 2025): 10-year modernization deal deploys Artis icono floor systems with AI-Rad Companion, boosting neurointerventional accuracy 35% across regional networks.

Canon Medical + Aquilion ONE (Oct 2025): FDA-cleared Alphenix 4D-CT C-arm integration enables real-time tumor ablation guidance with 2mm precision in 300 Tokyo labs serving 1.2M liver cancer cases.

Fujifilm + Annalise.ai (Sep 2025): SynergyVibe suite embeds AI prioritization engine, automating 85% workflow steps to accelerate time-sensitive embolization cases across 800 imaging centers.

📌 Buy Now & Unlock 360° Market Intelligence:https://www.datamintelligence.com/buy-now-page?report=interventional-imaging-market?prtk

Interventional Imaging Market Market Drivers :-

• Rising global burden of cardiovascular and chronic conditions boosts demand for image‐guided interventions.

• CVD remains a top cause of death worldwide, significantly increasing procedures like angioplasty and stent placement - driving the need for advanced interventional imaging.

• Patients and clinicians increasingly prefer minimally invasive over open surgeries due to shorter recovery times and lower risk.

• This preference directly expands interventional imaging utilization, underpinning an expected 12-13% CAGR in interventional imaging services by 2030

• Breakthroughs such as AI‐enhanced imaging, 3D/4D visualization, and hybrid imaging suites improve precision and safety in real time.

• Integration of AI is helping reduce procedural errors and improve diagnostics - a key reason providers are upgrading systems faster.

• Demand for mobile C‐arms and portable ultrasound devices is rising - especially in ambulatory centers and emerging economies.

• Portable imaging markets are projected to nearly double (e.g., from $2.8B in 2023 to $5.4B by 2030), supporting broader interventional imaging uptake.

• Healthcare systems are increasingly covering interventional procedures, encouraging adoption of advanced imaging tech.

• Investments in digital imaging and catheter labs are accelerating market penetration, especially in mature markets like North America.

Interventional Imaging Market Regional Insights:-

1. North America
North America holds the largest share of the interventional imaging market, representing around 40% of global revenue due to advanced healthcare infrastructure and high adoption of image‐guided procedures.
The U.S. dominates regional demand with strong R&D investment and widespread procedural adoption, driving steady growth.

2. Europe
Europe accounts for approximately 30% of the interventional imaging market share, backed by established healthcare systems and growing procedural demand.
Key markets such as Germany, the UK, and France contribute significantly, supported by aging populations and strong regulatory frameworks.

3. Asia‐Pacific
Asia‐Pacific commands about 35% of the regional share in the interventional imaging segment, with China leading within the region at over 35% share.
This region also shows the fastest CAGR forecast, driven by rising healthcare spending and expanding hospital networks.

Get Customization in the report as per your requirements:https://www.datamintelligence.com/customize/interventional-imaging-market?prtk

Interventional Imaging Market Market Segmentation
By Product Type: Includes imaging systems and accessories used in interventional procedures, such as catheters, needles, and contrast agents.

By Imaging Modality: Covers techniques like X-ray, MRI, CT, and ultrasound used to guide minimally invasive procedures.

By Application: Focuses on clinical areas such as cardiology, oncology, neurology, and vascular interventions.

By End-User: Targets hospitals, specialty clinics, ambulatory surgical centers, and diagnostic centers.

By Procedure Type: Categorizes based on minimally invasive interventions, such as biopsies, ablations, stent placements, and angiographies.

This research report delivers actionable insights, data-driven analysis, and future-ready perspectives that enable informed decision-making, reduce market risks, and uncover growth opportunities across the industry

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription
Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.